Cambridge Cognition, a Division of CeNeS Pharmaceuticals, Plans AIM Listing
10. September 2001 03:23 ET
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, Netherlands, Sept. 10, 2001 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced plans to float its cognition subsidiary, Cambridge Cognition, on AIM later in the...
CeNeS Launches Novel Pain Drug and Establishes Specialized Hospital Sales Force
06. September 2001 02:28 ET
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, UK, Sept. 5, 2001 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced that it has launched Xefo, a novel analgesic for the treatment of post-operative pain, in the...